Want to see IN:AKUMS full AI Analyst Report?
Akums Drugs and Pharmaceuticals Limited (AKUMS) Income Statement
4 Followers
Akums Drugs and Pharmaceuticals Limited Income Statement
Last quarter (Q4 2024), Akums Drugs and Pharmaceuticals Limited's total revenue was ₹10.08B. In Q4, Akums Drugs and Pharmaceuticals Limited's net income was ₹1.48B. See Akums Drugs and Pharmaceuticals Limited’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Mar 25 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| ₹ 40.71B | ₹ 43.59B | ₹ 40.20B | ₹ 34.75B | ₹ 36.47B | |
| ₹ 16.05B | ₹ 9.37B | ₹ 14.37B | ₹ 11.67B | ₹ 12.69B | |
| ₹ 12.95B | ₹ 5.70B | ₹ 10.78B | ₹ 9.76B | ₹ 9.47B | |
| Depreciation and Amortization | ₹ 1.53B | ₹ 1.55B | ₹ 1.26B | ₹ 1.13B | ₹ 946.79M |
| ₹ 5.29B | ₹ 6.31B | ₹ 1.31B | ₹ 3.09B | ₹ -821.80M | |
| ₹ 3.11B | ₹ 3.67B | ₹ 3.60B | ₹ 1.91B | ₹ 3.22B | |
| ₹ 346.02M | ₹ 146.28M | ₹ -4.05B | ₹ -410.17M | ₹ -5.15B | |
| ₹ 3.45B | ₹ 3.82B | ₹ -452.78M | ₹ 1.50B | ₹ -1.93B | |
| ₹ 3.38B | ₹ 2.55B | ₹ -40.35M | ₹ 948.55M | ₹ -2.53B | |
| Per Share Metrics | |||||
| Basic EPS | ₹ 22.60 | ₹ 16.67 | ₹ -0.28 | ₹ 6.03 | ₹ -16.04 |
| Diluted EPS | ₹ 22.60 | ₹ 16.67 | ₹ -0.28 | ₹ 6.03 | ₹ -16.04 |
| Weighted Average Shares Outstanding | 149.61M | 153.08M | 144.11M | 157.39M | 157.39M |
| Weighted Average Shares Outstanding (Diluted) | 149.61M | 153.08M | 157.39M | 157.39M | 157.39M |
Currency in INR
